Business news – Page 53
-
BusinessCrispr patent ruling breaks deadlock
Both sides claim victory as board rules patents do not interfere with each other
-
Business$2bn Immunomedics–Seattle Genetics deal delayed amid shareholder infighting
Major investor venBio seeks to derail deal and replace board members
-
ArticleIncreasing lab efficiencies through bespoke solutions
More custom products, more tailored packaging, more productivity
-
FeatureDeal or no deal?
Clare Sansom highlights recent changes in the landscape of pharma company collaborations and acquisitions
-
BusinessUniversity–industry collaborations aspire to pharmaceutical innovation
Three new UK partnerships illustrate drug research co-operation approaches that are growing in popularity
-
BusinessReckitt Benckiser to buy into baby milk
$17bn acquisition of Mead Johnson expands presence in developing markets, especially China
-
OpinionIn search of solvation
Process chemistry opens up a whole new world when it comes to solvent choice
-
BusinessDuPont settles fluorinated chemical lawsuits
DuPont and spinoff Chemours will pay more than $670m to settle around 3500 personal injury claims relating to PFOA exposure
-
BusinessAllergan to buy fat-freezing firm Zeltiq
$2.5bn deal adds to firm’s cosmetic and aesthetic treatments
-
BusinessDaiichi Sankyo to close R&D sites in India and Japan
Closures are part of an ongoing reorganisation aimed at increasing productivity
-
BusinessUS biotech leaders protest immigration ban
Donald Trump’s suspended order would endanger America’s biotech industry if re-instated
-
BusinessFatal liquid nitrogen release at US sperm bank
Workplace safety agency to probe death of deputy sheriff after apparent asphyxiation at Xytex in Augusta
-
CareersHold SME back: threats to small business growth
Finding staff is now the leading barrier to growth for UK SMEs
-
BusinessSabic takes control of Shell petrochemicals joint venture
$820m sale of Saudi Arabian plants continues Shell’s global reorganisation programme
-
OpinionHow much is your chief executive worth?
The executive pay and equality debate is here to stay
-
BusinessLilly buys CoLucid for migraine drugs
US firm also laying off 485 sales staff after Alzheimer’s drug failure
-
BusinessMerck & Co settles cancer antibody patent dispute
US firm will pay Bristol-Myers Squibb and Ono $625m plus royalties on future sales of immunotherapy
-
BusinessTeva hit with fines and patent loss
Double whammy as firm settles subsidiary pay-for-delay suit and courts invalidate patents on multiple sclerosis drug
-
BusinessJ&J to buy Actelion for $30bn
Actelion’s R&D will spin out as a new company, while Janssen will take on in-market and late-stage medicines
-
BusinessBiogen pays $1.25bn to protect multiple sclerosis drug sales
Agreement with Forward Pharma gives Biogen license to keep selling blockbuster Tecfidera